UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005760
Receipt number R000006808
Scientific Title Cancer Dyspnea Relief Trial
Date of disclosure of the study information 2011/07/01
Last modified on 2018/09/04 11:47:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cancer Dyspnea Relief Trial

Acronym

CDR Trial

Scientific Title

Cancer Dyspnea Relief Trial

Scientific Title:Acronym

CDR Trial

Region

Japan


Condition

Condition

Dyspnea in cancer patient

Classification by specialty

Not applicable

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare the efficacy of oxycodone to dyspnea in cancer patients with morphine

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase III


Assessment

Primary outcomes

mean change in intensity of dyspnea evaluated by NRS at 60 minutes after taking investigational drug in each group.

Key secondary outcomes

(1) mean change in intensity of dyspnea evaluated by NRS at 120 minutes after taking investigational drug in each group.
(2)the rate of the patietnts with more than 1 reduction in dyspnea intensity evaluated by NRS at 60 and 120 minutes after taking investigational drug in each group.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

immediate release oxycodone

Interventions/Control_2

immediate release morphine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) written consent
(2) inpatient or outpatient
(3) localy advanced or metastatic disease
(4)prescribed SR oxycodone 20-200mg/day for regular analgesics
(5) clinically clear consiousness
(6) intensity of dyspnea in rest more than 3 in NRS
(7) SpO2 > 90%, with supplimental oxygen if needed
(8) ECOG PS 0-3

Key exclusion criteria

(1) anemia is a cause of dyspnea
(2) acute respiratory failure
(3) decompensated heart failure
(4) impairment of liver function: 5 times higher than upper normal value of AST or ALT, or total bilirubin > 2mg/dl
(5) renal insufficiency : twice higher than upper normal value of Cr
(6) bacterial enteritis
(7) unstable pain: more than 5 in NRS(0-10) and plan to increase opioid within next 24hr
(8) expected prognosis is less than 1 month
(9) hypersensitivity to opium alkaloid
(10) opioid rescue use for pain within 9 hour before taking investigational drug
(11) opioid analgesic use for any symptoms other than pain within 24 hour before taking investigational drug
(12) history of taking opioid rescue for dyspnea
(13) prescribed codein, morphine, fentanyl, tramadol, or buprenorphine as regular medication
(14) those who is considered not to be qualified for this trial by primary responsible doctor

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoru Tsuneto

Organization

Osaka University

Division name

Graduate School of Medicine

Zip code


Address

2-2 Yamadaoka, Suita, Osaka

TEL

06-6879-3867

Email

tsuneto@pm.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takashi Yamaguchi

Organization

Kobe University hospital

Division name

Department of Palliative Medicine

Zip code


Address

7-5-1 Kusunokicho, Chuo ward, Kobe, Hyogo

TEL

078-382-6531

Homepage URL


Email

ikagoro@pop06.odn.ne.jp


Sponsor or person

Institute

Osaka University

Institute

Department

Personal name



Funding Source

Organization

Japanese Society of Palliative Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

旭川医科大学病院 (北海道)
淀川キリスト教病院 (大阪府)
岡山済生会総合病院 (岡山県)
静岡県立がんセンター (静岡県)
九州がんセンター (福岡県)
山形大学附属病院 (山形県)
手稲渓仁会病院 (北海道)
山形県立中央病院 (山形県)
国立がん研究センター東病院 (千葉県)
県立広島病院 (広島県)
名古屋市立大学病院 (愛知県)
神戸大学医学部附属病院 (兵庫県)
国立病院機構 大阪医療センター (大阪府)
大阪大学附属病院(大阪府)
静岡済生会総合病院 (静岡県)
亀田総合病院 (千葉県)
KKR札幌医療センター (北海道)
都立駒込病院 (東京都)
筑波大学附属病院 (茨城県)
東札幌病院 (北海道)
筑波メディカルセンター病院 (茨城県)
ガラシア病院 (大阪府)
聖隷三方原病院 (静岡県)
聖隷浜松病院 (静岡県)
新潟市民病院 (新潟県)
佐久総合病院 (長野県)
小牧市民病院 (愛知県)
市立岸和田市民病院(大阪府)
近畿中央胸部疾患センター(大阪府)
近畿大学医学部付属病院(大阪府)
大阪府立呼吸器アレルギー医療センター(大阪府)
関西電力病院(大阪府)
天理よろづ相談所病院(奈良県)


Other administrative information

Date of disclosure of the study information

2011 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://academic.oup.com/jjco

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 03 Month 12 Day

Date of IRB


Anticipated trial start date

2012 Year 08 Month 01 Day

Last follow-up date

2014 Year 06 Month 30 Day

Date of closure to data entry

2014 Year 06 Month 30 Day

Date trial data considered complete

2016 Year 07 Month 01 Day

Date analysis concluded

2018 Year 04 Month 30 Day


Other

Other related information



Management information

Registered date

2011 Year 06 Month 12 Day

Last modified on

2018 Year 09 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006808


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name